Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force - Wikidata - awgldk - TriplyDB

Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force

Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force

http://www.wikidata.org/entity/Q28595920

about

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?Prevention of Epilepsy: Issues and Innovations.Family Cohesion, Stigma, and Quality of Life in Dyads of Children With Epilepsy and Their Parents.Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients.Advocacy for children with epilepsy: Leveraging the WHA resolution. Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy.

P2860

Q28074736-8879036D-0DA7-4368-A708-A21169532180 Q36339575-E7596FF9-9219-411C-971D-5264C33B66C0 Q38954567-CC422F97-20E7-4C9C-9C9A-ABC69368BD81 Q38991115-97BAFDE9-391E-4821-8196-88DA1AC173FE Q47244043-BDC67C77-AB90-4C90-803D-4187D6D083F8 Q55277254-1620A025-44D8-469A-887D-3762C9F7A313

P2860

Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force

http://www.wikidata.org/entity/Q28595920

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@ast

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@en

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@nl

type

label

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@ast

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@en

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@nl

prefLabel

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@ast

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@en

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@nl

P1433

Q28595920-D07A168D-0C2D-41B7-9F80-C8CE789048A4

P1476

Q28595920-32CF0D2B-35B7-4D27-B28C-8E0B94896E42

P2093

Q28595920-11F3DA96-E6C1-4F83-8AB4-F8DE8E41477E

Q28595920-2E9DECE3-7448-467F-8AC0-E67FC8865CC0

Q28595920-39A3CA58-F37A-4678-9A9C-458AEEA5E5B3

Q28595920-62C4FED8-EC58-4F87-A7F5-9CA1BE03AAD0

Q28595920-693A0EAE-077E-4A02-A94E-DA32671371BB

Q28595920-7A47229E-E6E6-4E78-A685-3B82C675AEA2

Q28595920-C5E58608-AC16-41A3-A4C3-7B93778A2819

Q28595920-E529B5D8-A7BD-4BA2-9A78-C008E1E45862

Q28595920-FACC019C-FCF1-41A6-8D72-6978D2D38227

P275

Q28595920-E49B18E9-B3D1-45AB-98C9-D60213F2F1EF

P2860

Q28595920-066C4C82-BEE6-4E63-A9BA-3C8F523BAAC3

Q28595920-0EEA666D-44B1-4804-97BA-10E73AB5F06A

Q28595920-0FDF6B70-7252-48EE-9FFF-BF395C492EDE

Q28595920-1362B302-CFA9-4782-AC29-CA13ADD683A9

Q28595920-1A92097E-FAAB-419E-8A05-3F99F91573DA

Q28595920-24877B0D-0B65-49A1-B076-D901F711866E

Q28595920-2A1FE987-67B2-4467-8446-6624281EEC82

Q28595920-2B57914A-3B7A-4319-9007-86E669DDF1A5

Q28595920-327A1DCD-2854-4830-B6F4-42BE9A4E9282

Q28595920-3361CFD5-BA4E-4BAB-9685-25B35452DDBF

P304

Q28595920-20C7F1C6-A9DC-4212-B311-8E08A2E97C71

P31

Q28595920-CD6E100C-EACB-44E9-BE4A-6D2A10E0EE16

Q28595920-D092FFF7-0CCB-449A-82E6-CDBDB37112E8

P3181

Q28595920-539E16A7-B558-42A6-A100-F117B0D0328C

P356

Q28595920-DDF67833-DDD0-4633-9E99-73FB5524E4F6

P407

Q28595920-81990B32-BCB9-4461-A5EB-47D733573A59

P433

Q28595920-659F869F-4520-4A07-86F6-6FC7C4A06951

P478

Q28595920-BD41C65B-DE7E-4766-9AB1-B8F2E2B32519

P50

Q28595920-6505077D-EADF-4A52-9C22-20D732709590

Q28595920-CB02C090-AC1B-4FC8-ABAF-1B4616DCBB29

P5008

Q28595920-C26E06E1-0DE5-4564-B6BD-A70E3112C4D5

P577

Q28595920-2DB6162E-0FC6-4E24-A58D-8D463F78BDF5

Q28595920-9FC13163-71F8-498C-A6F7-CA72E4316CB5

P5875

Q28595920-EDD35FF3-994E-46CA-984C-086D009A49C2

P698

Q28595920-D6CAC2FB-E557-4EB9-9E6A-B2682654C2FD

P921

Q28595920-2D7C915C-8454-41A0-B467-079D09DEA935

P932

Q28595920-006EE8C4-ECCE-4004-A368-1ADAC18F7C49

P3181

P356

P1433

P1476

Epilepsy priorities in Europe: ...... psy Advocacy Europe Task Force

@en

P2093

Ann Little

http://www.w3.org/2001/XMLSchema#string

Asla Pitkänen

http://www.w3.org/2001/XMLSchema#string

Christian Elger

http://www.w3.org/2001/XMLSchema#string

Hanneke de Boer

http://www.w3.org/2001/XMLSchema#string

Janet Mifsud

http://www.w3.org/2001/XMLSchema#string

Michel Baulac

http://www.w3.org/2001/XMLSchema#string

Mike Glynn

http://www.w3.org/2001/XMLSchema#string

Philippe Ryvlin

http://www.w3.org/2001/XMLSchema#string

Reetta Kälviäinen

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Identification of new epilepsy treatments: issues in preclinical methodology

Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project

Uncovering the neurobehavioural comorbidities of epilepsy over the lifespan

Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009

Epilepsy biomarkers.

Epilepsy across the spectrum: promoting health and understanding. A summary of the Institute of Medicine report

GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior

MR-guided stereotactic laser ablation of epileptogenic foci in children.

An optogenetic approach in epilepsy.

The impact of epilepsy on patients' lives.

P304

1687-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2593835

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/EPI.13201

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Reetta Kälviäinen

P5008

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282344341

http://www.w3.org/2001/XMLSchema#string

P698

26415919

http://www.w3.org/2001/XMLSchema#string

P921

P932

5019256

http://www.w3.org/2001/XMLSchema#string